Sumitomo Dainippon Pharma has asked Japanese authorities to approve its Trerief (zonisamide) as a new therapy for parkinsonism in dementia patients with Lewy bodies, the company announced in a press release. Trerief went on sale in Japan in March 2009 as a treatment for Parkinson’s patients who saw insufficient…
The biopharmaceutical company Cavion announced the appointment of a new executive vice president of research and development and chief medical officer to lead efforts advancing therapies based on the company’s T-type calcium channel (Cav3) platform targeting neurological diseases such as Parkinson’s disease (PD). Spyridon “Spyros” Papapetropoulos, MD, PhD, has been named the…
The Parkinson’s Foundation will award $1.2 million to early career scientists working on Parkinson’s disease research in 27 new career development and fellowship grants. Xi Chen, PhD, of the Van Andel Research Institute, was called a “standout grand recipient” this year. Chen is using a $100,000 postdoctoral fellowship…
The United States is just four days away from sending a SpaceX rocket to the International Space Station whose cargo will include a Parkinson’s disease experiment. National Aeronautics and Space Administration officials said the experiment will involve growing leucine-rich repeat kinase 2 protein crystals in the near-zero-gravity conditions of space. Scientists…
The Parkinson’s Foundation has started a podcast series on new research findings, advice for those with the disease and their families, and other topics. The podcasts, hosted by Dr. Dan Keller, are being streamed live, and can be downloaded afterward. The series is titled “Substantial Matters: Life and Science of Parkinson’s.” A…
Peter Istvan and David Newall founded “Pedaling for Parkinson’s” in 2011 as an annual cycling fundraising event to support Parkinson’s Canada and the Parkinson’s disease (PD) community. This year, “Pedaling for Parkinson’s” reached a new cumulative milestone, raising more than $1 million, which was made possible with the help of…
The cognitive science company Cogstate received approval to market a new digital cognitive assessment tool to assist healthcare professionals in measuring cognition in patients ages 6 to 99, either in-clinic or at home. This tool, called the Cognigram, could help measure the progression of Parkinson’s disease and other illnesses. The Cognigram can…
Acadia Pharmaceuticals, the maker of Nuplazid (pimavanserin), an oral medication to treat hallucinations and delusions associated with Parkinson’s disease (PD), was ranked 11th on Forbes Magazine’s 2017 list of the “World’s Most Innovative Growth Companies.” Forbes’ ranking is based on the ‘innovation premium’ of each…
Hong Kong has issued a patent to Intec Pharma for its investigational Accordion Pill Carbidopa/Levodopa (AP-CD/LD) drug delivery for Parkinson’s disease symptoms in advanced patients. The patent (HK1158545) is titled “Carbidopa/Levodopa Gastroretentive Drug Delivery” and is scheduled to remain active until April 2029. The patent belongs to Intec’s IN-7 patent family that…
The Parkinson’s Disease Digital Biomarker DREAM Challenge was just launched by Sage Bionetworks as the first of a series of open, crowd-funded projects designed to help researchers identify ways to use smartphones and remote sensing devices to monitor health and disease. The first DREAM Challenge will focus on…
Get regular updates to your inbox.